Kyunggi-do, South Korea

Tae Kyun Lim


Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Pharmaceuticals: Tae Kyun Lim

Introduction: Tae Kyun Lim is a notable inventor based in Kyunggi-do, South Korea. With a focus on advancements in pharmaceuticals, he has contributed to the field with his innovative research. His work specifically targets male sexual dysfunction through the development of unique compounds.

Latest Patents: Tae Kyun Lim holds one patent titled “Pyrazolopyrimidinone derivatives for the treatment of impotence.” This invention explores specific pyrazolopyrimidinone derivatives, detailing their preparation methods and pharmaceutical compositions. The compounds outlined in this patent have shown promise in treating impotence while minimizing side effects, marking a significant advancement in the treatment of male sexual dysfunction.

Career Highlights: Tae Kyun Lim is associated with Dong-a Pharmaceutical Co., Ltd., a company known for its commitment to innovative healthcare solutions. His role within the company reflects his dedication to developing transformative treatments in the medical field.

Collaborations: Throughout his career, Tae Kyun Lim has collaborated with esteemed colleagues, including Moohi Yoo and Wonbae Kim. Their teamwork has been instrumental in advancing research and pushing the boundaries of pharmaceutical inventions.

Conclusion: In summary, Tae Kyun Lim stands out as a promising inventor in the pharmaceutical industry. His patent on pyrazolopyrimidinone derivatives represents a leap forward in the treatment of impotence, showcasing his commitment to improving male sexual health through innovation. As he continues his work at Dong-a Pharmaceutical Co., Ltd., the future holds great potential for his contributions to medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…